태아 이수성 확인 검사 시장 보고서(2026년)

Fetal aneuploidy confirmation testing refers to diagnostic procedures that verify chromosomal abnormalities in a fetus following an initial screening indicating elevated risk. These tests often involve invasive techniques such as amniocentesis or chorionic villus sampling to directly examine fetal chromosomes. They provide definitive information about conditions like trisomy 21, trisomy 18, and trisomy 13 by evaluating chromosome number and structure.

The primary test types of fetal aneuploidy confirmation testing include non-invasive prenatal testing, invasive testing, and other variants. Non-invasive prenatal testing analyzes cell-free fetal DNA from maternal blood to detect chromosomal abnormalities. Technologies include next-generation sequencing, polymerase chain reaction, fluorescence in situ hybridization, microarray, and others. Applications include trisomy, sex chromosome aneuploidy, microdeletions, and others, serving hospitals, diagnostic laboratories, specialty clinics, and other end-users.

Tariffs on imported sequencing platforms, microarray equipment, reagents, and laboratory consumables have influenced the fetal aneuploidy confirmation testing market by raising operational costs for diagnostic laboratories and hospitals. Regions such as North America and Europe that depend on advanced genetic testing instruments from global suppliers face increased procurement expenses, particularly affecting next-generation sequencing and microarray segments. Smaller specialty clinics may experience slower technology adoption due to higher capital costs. However, tariffs are also encouraging domestic production of genetic testing reagents and laboratory technologies, fostering local innovation and strengthening regional genomic testing capabilities.

The fetal aneuploidy confirmation testing market research report is one of a series of new reports from The Business Research Company that provides fetal aneuploidy confirmation testing market statistics, including fetal aneuploidy confirmation testing industry global market size, regional shares, competitors with a fetal aneuploidy confirmation testing market share, detailed fetal aneuploidy confirmation testing market segments, market trends and opportunities, and any further data you may need to thrive in the fetal aneuploidy confirmation testing industry. This fetal aneuploidy confirmation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fetal aneuploidy confirmation testing market size has grown rapidly in recent years. It will grow from $1.43 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising maternal age pregnancies, increasing prevalence of chromosomal abnormalities, growing awareness of prenatal screening programs, advancements in cytogenetic testing methods, expansion of hospital-based diagnostic laboratories.

The fetal aneuploidy confirmation testing market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, growing integration of ai-based genetic analysis tools, rising demand for non-invasive prenatal testing confirmation, expansion of genomic research initiatives, increasing healthcare infrastructure investments in emerging markets. Major trends in the forecast period include increasing adoption of next-generation sequencing technologies, rising demand for early and accurate prenatal diagnosis, growing preference for confirmatory diagnostic testing after positive screening, expansion of advanced chromosomal microarray analysis, increasing availability of specialized prenatal diagnostic services.

The rising maternal age is anticipated to drive the growth of the fetal aneuploidy confirmation testing market in the coming years. Maternal age refers to the age of a woman when she becomes pregnant or delivers a child. The increase in maternal age is attributed to women postponing childbirth to pursue higher education and prioritize career development before starting a family. Fetal aneuploidy confirmation testing mitigates the risks linked to increasing maternal age by accurately detecting chromosomal abnormalities that are more prevalent in pregnancies among older women, enabling timely medical guidance and well-informed pregnancy decisions. For example, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the average age of mothers at first birth rose from 27.4 years in 2022 to 27.5 years in 2023, representing an increase of 0.1 years. Therefore, the rise in maternal age is fueling the growth of the fetal aneuploidy confirmation testing market.

The expansion of personalized medicine is expected to drive the growth of the fetal aneuploidy confirmation testing market in the coming years. Personalized medicine is a healthcare approach that customizes prevention, diagnosis, and treatment strategies according to an individual's unique genetic profile, biomarkers, and molecular characteristics. The adoption of personalized medicine is rising due to rapid advancements in genomic technologies and biomarker-based diagnostics, which allow clinicians to tailor treatments and interventions to an individual's genetic makeup. Fetal aneuploidy confirmation testing supports personalized medicine by providing accurate genetic information about the fetus, enabling healthcare providers to customize prenatal care, risk management, and treatment decisions specifically to the genetic profile of each pregnancy. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized therapies for patients with rare diseases, reflecting a significant increase from the six approvals recorded in 2022. Therefore, the growth of personalized medicine is driving the expansion of the fetal aneuploidy confirmation testing market.

The increasing prevalence of chromosomal abnormalities is expected to propel the growth of the fetal aneuploidy confirmation testing market in the coming years. Chromosomal abnormalities are genetic disorders resulting from changes in chromosome number or structure, leading to conditions such as trisomies and other aneuploidies. The prevalence of these abnormalities is rising due to increasing maternal age, as older maternal age is linked to a higher risk of errors during cell division that result in conditions like trisomies and other aneuploidies. Fetal aneuploidy confirmation testing facilitates the detection and confirmation of chromosomal abnormalities in the developing fetus by analyzing genetic material, allowing early diagnosis, informed clinical decisions, and timely management of conditions such as trisomies and other aneuploidies. For example, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, approximately 5,700 babies are born with Down syndrome in the United States each year, corresponding to roughly 1 in every 640 births. Therefore, the increasing prevalence of chromosomal abnormalities is driving the growth of the fetal aneuploidy confirmation testing market.

Major companies operating in the fetal aneuploidy confirmation testing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., SYNLAB AG, Myriad Genetics Inc., CapitalBio Technology Co. Ltd., BGI Genomics Co. Ltd., Centogene N.V., Yourgene Health plc, MedGenome Labs Ltd., Fulgent Genetics Inc., Annoroad Gene Technology Co. Ltd., CeGaT GmbH, LifeCodexx AG, Variantyx Inc., Igenomix S.L.U.

North America was the largest region in the fetal aneuploidy confirmation testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fetal aneuploidy confirmation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fetal aneuploidy confirmation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fetal aneuploidy confirmation testing market consists of revenues earned by entities by providing services such as genetic counseling, diagnostic sampling procedures including amniocentesis and chorionic villus sampling, laboratory-based cytogenetic analysis, and rapid aneuploidy detection. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fetal Aneuploidy Confirmation Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses fetal aneuploidy confirmation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fetal aneuploidy confirmation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fetal aneuploidy confirmation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Test Type: Non-Invasive Prenatal Testing; Invasive Testing; Other Test Types
• 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Fluorescence In Situ Hybridization; Microarray; Other Technologies
• 3) By Application: Trisomy; Sex Chromosome Aneuploidy; Microdeletions; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Non-Invasive Prenatal Testing: Cell-Free Fetal Deoxyribonucleic Acid Testing; Maternal Serum Screening; Ultrasound-Based Risk Assessment; Next-Generation Sequencing-Based Non-Invasive Prenatal Testing; Chromosomal Microarray Analysis
• 2) By Invasive Testing: Amniocentesis; Chorionic Villus Sampling; Cordocentesis; Fetal Biopsy; Fetal Karyotyping
• 3) By Other Test Types: Preimplantation Genetic Testing; Targeted Gene Panels; Multiplex Polymerase Chain Reaction Testing; Fluorescence In Situ Hybridization Testing; Comparative Genomic Hybridization Testing
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; SYNLAB AG; Myriad Genetics Inc.; CapitalBio Technology Co. Ltd.; BGI Genomics Co. Ltd.; Centogene N.V.; Yourgene Health plc; MedGenome Labs Ltd.; Fulgent Genetics Inc.; Annoroad Gene Technology Co. Ltd.; CeGaT GmbH; LifeCodexx AG; Variantyx Inc.; Igenomix S.L.U.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Fetal Aneuploidy Confirmation Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Fetal Aneuploidy Confirmation Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Fetal Aneuploidy Confirmation Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Fetal Aneuploidy Confirmation Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption of Next-Generation Sequencing Technologies
  • 4.2.2 Rising Demand for Early And Accurate Prenatal Diagnosis
  • 4.2.3 Growing Preference For Confirmatory Diagnostic Testing After Positive Screening
  • 4.2.4 Expansion Of Advanced Chromosomal Microarray Analysis
  • 4.2.5 Increasing Availability Of Specialized Prenatal Diagnostic Services

5. Fetal Aneuploidy Confirmation Testing Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Specialty Clinics
• 5.4 Fertility Centers
• 5.5 Academic And Research Institutes

6. Fetal Aneuploidy Confirmation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Fetal Aneuploidy Confirmation Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Fetal Aneuploidy Confirmation Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Fetal Aneuploidy Confirmation Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Fetal Aneuploidy Confirmation Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Fetal Aneuploidy Confirmation Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Fetal Aneuploidy Confirmation Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Fetal Aneuploidy Confirmation Testing Market Segmentation

• 9.1. Global Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Invasive Prenatal Testing, Invasive Testing, Other Test Types
• 9.2. Global Fetal Aneuploidy Confirmation Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Other Technologies
• 9.3. Global Fetal Aneuploidy Confirmation Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Trisomy, Sex Chromosome Aneuploidy, Microdeletions, Other Applications
• 9.4. Global Fetal Aneuploidy Confirmation Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Specialty Clinics, Other End Users
• 9.5. Global Fetal Aneuploidy Confirmation Testing Market, Sub-Segmentation Of Non-Invasive Prenatal Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Free Fetal Deoxyribonucleic Acid Testing, Maternal Serum Screening, Ultrasound-Based Risk Assessment, Next-Generation Sequencing-Based Non-Invasive Prenatal Testing, Chromosomal Microarray Analysis
• 9.6. Global Fetal Aneuploidy Confirmation Testing Market, Sub-Segmentation Of Invasive Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Amniocentesis, Chorionic Villus Sampling, Cordocentesis, Fetal Biopsy, Fetal Karyotyping
• 9.7. Global Fetal Aneuploidy Confirmation Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preimplantation Genetic Testing, Targeted Gene Panels, Multiplex Polymerase Chain Reaction Testing, Fluorescence In Situ Hybridization Testing, Comparative Genomic Hybridization Testing

10. Fetal Aneuploidy Confirmation Testing Market Regional And Country Analysis

• 10.1. Global Fetal Aneuploidy Confirmation Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Fetal Aneuploidy Confirmation Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Fetal Aneuploidy Confirmation Testing Market

• 11.1. Asia-Pacific Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Fetal Aneuploidy Confirmation Testing Market

• 12.1. China Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Fetal Aneuploidy Confirmation Testing Market

• 13.1. India Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Fetal Aneuploidy Confirmation Testing Market

• 14.1. Japan Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Fetal Aneuploidy Confirmation Testing Market

• 15.1. Australia Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Fetal Aneuploidy Confirmation Testing Market

• 16.1. Indonesia Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Fetal Aneuploidy Confirmation Testing Market

• 17.1. South Korea Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Fetal Aneuploidy Confirmation Testing Market

• 18.1. Taiwan Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Fetal Aneuploidy Confirmation Testing Market

• 19.1. South East Asia Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Fetal Aneuploidy Confirmation Testing Market

• 20.1. Western Europe Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Fetal Aneuploidy Confirmation Testing Market

• 21.1. UK Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Fetal Aneuploidy Confirmation Testing Market

• 22.1. Germany Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Fetal Aneuploidy Confirmation Testing Market

• 23.1. France Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Fetal Aneuploidy Confirmation Testing Market

• 24.1. Italy Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Fetal Aneuploidy Confirmation Testing Market

• 25.1. Spain Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Fetal Aneuploidy Confirmation Testing Market

• 26.1. Eastern Europe Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Fetal Aneuploidy Confirmation Testing Market

• 27.1. Russia Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Fetal Aneuploidy Confirmation Testing Market

• 28.1. North America Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Fetal Aneuploidy Confirmation Testing Market

• 29.1. USA Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Fetal Aneuploidy Confirmation Testing Market

• 30.1. Canada Fetal Aneuploidy Confirmation Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Fetal Aneuploidy Confirmation Testing Market

• 31.1. South America Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Fetal Aneuploidy Confirmation Testing Market

• 32.1. Brazil Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Fetal Aneuploidy Confirmation Testing Market

• 33.1. Middle East Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Fetal Aneuploidy Confirmation Testing Market

• 34.1. Africa Fetal Aneuploidy Confirmation Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Fetal Aneuploidy Confirmation Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Fetal Aneuploidy Confirmation Testing Market Regulatory and Investment Landscape

36. Fetal Aneuploidy Confirmation Testing Market Competitive Landscape And Company Profiles

• 36.1. Fetal Aneuploidy Confirmation Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Fetal Aneuploidy Confirmation Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Fetal Aneuploidy Confirmation Testing Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Fetal Aneuploidy Confirmation Testing Market Other Major And Innovative Companies

• Illumina Inc., PerkinElmer Inc., SYNLAB AG, Myriad Genetics Inc., CapitalBio Technology Co. Ltd., BGI Genomics Co. Ltd., Centogene N.V., Yourgene Health plc, MedGenome Labs Ltd., Fulgent Genetics Inc., Annoroad Gene Technology Co. Ltd., CeGaT GmbH, LifeCodexx AG, Variantyx Inc., Igenomix S.L.U.

38. Global Fetal Aneuploidy Confirmation Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Fetal Aneuploidy Confirmation Testing Market

41. Fetal Aneuploidy Confirmation Testing Market High Potential Countries, Segments and Strategies

• 41.1 Fetal Aneuploidy Confirmation Testing Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Fetal Aneuploidy Confirmation Testing Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Fetal Aneuploidy Confirmation Testing Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer